Actinium Pharmaceuticals ATNM
NYSE ATNM
$1.18 +0.04 (+3.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Actinium Pharmaceuticals (ATNM) Selling, General & Administrative (2012 - 2026)

Updated

Actinium Pharmaceuticals (ATNM) reported Selling, General & Administrative of $2.06 million for Q2 2026, down 21.6% from $2.62 million a year earlier but up 20.9% from the prior quarter.

Analysis

Actinium Pharmaceuticals (ATNM) Selling, General & Administrative (2012 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Actinium Pharmaceuticals' Selling, General & Administrative came in at $7.41 million, down 56.6% year-over-year; for FY2025, it was $15.21 million, up 26.0% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of 19.3% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $12.08 million in FY2024 (-9.4%), $13.33 million in FY2023 (+11.1%), $12 million in FY2022 (+48.6%) and $8.08 million in FY2021 (+28.0%).
  • Five-year quarterly Selling, General & Administrative spans a low of $1.53 million in Q3 2025 and a high of $8.94 million in Q1 2025.
  • Year over year, Selling, General & Administrative has now declined in each of the last five quarters, with growth averaging 3.2% over the last eight quarters.
  • The high point for year-over-year Selling, General & Administrative in five years was Q1 2025 (growth of 201.8%); the low point was Q1 2026 (a decline of 81.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.7 million (Q1 2026), $2.12 million (Q4 2025) and $1.53 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Actinium Pharmaceuticals 37.10 Mn 37.10 Mn - 2.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.06 Mn
Mar 31, 2026 1.70 Mn
Dec 31, 2025 2.12 Mn
Sep 30, 2025 1.53 Mn
Jun 30, 2025 2.62 Mn
Mar 31, 2025 8.94 Mn
Dec 31, 2024 2.69 Mn
Sep 30, 2024 2.83 Mn
Jun 30, 2024 3.59 Mn
Mar 31, 2024 2.96 Mn
Dec 31, 2023 2.31 Mn
Sep 30, 2023 2.73 Mn
Jun 30, 2023 4.56 Mn
Mar 31, 2023 3.74 Mn
Dec 31, 2022 3.96 Mn
Sep 30, 2022 3.07 Mn
Jun 30, 2022 3.23 Mn
Mar 31, 2022 1.74 Mn
Dec 31, 2021 2.66 Mn
Sep 30, 2021 1.99 Mn
API Access

Actinium Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ATNM&period=max&api_key=YOUR_API_KEY